 | ||||||||||
 |
 |
 |
|
 |
|
 |
|
 |
|
 |
|
|
|
| ||
Haig Keledjian, Chairman of the Board Mr. Keledjian has been instrumental in guiding the growth and development of Viral Genetics, Inc., having acted as its Chairman, Chief Executive Officer and President since its 1995 founding. He has overseen the completion of VGV-1’s five human clinical trials, including the recently completed Phase III trial in South Africa, the creation of Viral Genetics’ global intellectual property portfolio and the financing of Viral Genetics. Mr. Keledjian is a California attorney. Prior to joining Viral Genetics, he practiced tax and estate law. Back to Corporate Governance And Board of Directors' Page Select another Biography: Board of Directors:
|
|
|
|
Home | About Us | Our Team | Advisory Board | Discovery Our Vision | Immune-Based Therapies | TNP | Development | VGV-1 History | Product Timeline | Clinical Trials Press Releases | Media Kits | Media Inquiries | News Subscription Service Investor Contacts | Email Alerts | Contact Us | SEC Filings Glossary | Stock Information | Corporate Governance & Board of Directors University of Colorado License | Careers |
|
|
 |
|
|
